VeDOlizumab PERsistence in IBD patients after switching from intravenous to subcutaneous administration: a real-life multicenter study The DOPER study
12-month French multicenter, observational, prospective cohort study
Investigateurs
- Dr Nicolas MATHIEU
La fiche complète est accessible aux membres du GETAID.
Se connecter